Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials

被引：0
作者：
Kani, R. [1 ]
Watanabe, A. [2 ]
Miyamoto, Y. [3 ]
Kuno, T. [4 ]
机构：
[1] Kameda Med Ctr, Kamogawa, Japan
[2] Univ Tsukuba, Div Hosp Med, Ibaraki, Japan
[3] Ctr Dis Control & Prevent, Div Diabet Translat, Surveillance Econ & Stat Branch, Atlanta, GA USA
[4] Albert Einstein Coll Med, Div Cardiol, Montefiore Med Ctr, New York, NY USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
[31]   Influence of Sodium-Glucose Cotransporter-2 Inhibitors on Plasma Adiponectin in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials [J].
Wang, Yang ;
Xia, Ning .
HORMONE AND METABOLIC RESEARCH, 2022, 54 (12) :833-844
[32]   Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review [J].
Rahman, Hammad ;
Khan, Safi U. U. ;
Lone, Ahmad N. N. ;
Ghosh, Priyanka ;
Kunduru, Mahathi ;
Sharma, Saurabh ;
Sattur, Sudhakar ;
Kaluski, Edo .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (16)
[33]   Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention [J].
Reid, Jessica ;
Rana, Khyatiben ;
Niman, Stephanie ;
Sheikh-Ali, Mae ;
Lewis, Todd ;
Choksi, Rushab R. ;
Goldfaden, Rebecca F. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) :419-429
[34]   Role of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors [J].
Lusk, Kathleen A. ;
Barnes, Nicole E. .
US PHARMACIST, 2016, 41 (11) :38-42
[35]   Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention [J].
Jessica Reid ;
Khyatiben Rana ;
Stephanie Niman ;
Mae Sheikh-Ali ;
Todd Lewis ;
Rushab R. Choksi ;
Rebecca F. Goldfaden .
American Journal of Cardiovascular Drugs, 2020, 20 :419-429
[36]   Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke [J].
Kimura, Genjiro .
CIRCULATION JOURNAL, 2017, 81 (06) :898-898
[37]   Evaluating the overall renal outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with chronic kidney disease (CKD) [J].
Cao, Min-Jia ;
Liang, Ting-Ting ;
Xu, Li ;
Shi, Fang-Hong .
DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01)
[38]   Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Lin, Norman H. Y. ;
Ho, Jamie S. Y. ;
Leow, Aloysius S. T. ;
Teo, Yao Hao ;
Yeo, Brian S. Y. ;
Zhang, Audrey A. Y. ;
Goh, Fang Qin ;
Yeo, Tiong-Cheng ;
Wong, Raymond C. C. ;
Chai, Ping ;
Chan, Mark Y. Y. ;
Sia, Ching-Hui .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (01) :71-81
[39]   Sodium-glucose cotransporter-2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis [J].
Mascolo, Annamaria ;
Rafaniello, Concetta ;
di Mauro, Gabriella ;
Ruggiero, Donatella ;
Campitiello, Maria Rosaria ;
Donniacuo, Maria ;
Berrino, Pasquale Maria ;
Rossi, Francesco ;
Paolisso, Giuseppe ;
Capuano, Annalisa .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[40]   The sodium-glucose cotransporter-2 (SGLT2) inhibitors synergize with nitric oxide and prostacyclin to reduce human platelet activation [J].
Lescano, Caroline Honaiser ;
Leonardi, Guilherme ;
Portugal Torres, Pedro Henrique ;
Amaral, Tiago Nardi ;
de Freitas Filho, Luiz Henrique ;
Antunes, Edson ;
Vicente, Cristina Pontes ;
Anhe, Gabriel Forato ;
Monica, Fabiola Zakia .
BIOCHEMICAL PHARMACOLOGY, 2020, 182
12345